|
Name |
6-Methoxymethyleugenin
|
Molecular Formula | C13H14O5 | |
IUPAC Name* |
5-hydroxy-7-methoxy-6-(methoxymethyl)-2-methylchromen-4-one
|
|
SMILES |
CC1=CC(=O)C2=C(C(=C(C=C2O1)OC)COC)O
|
|
InChI |
InChI=1S/C13H14O5/c1-7-4-9(14)12-11(18-7)5-10(17-3)8(6-16-2)13(12)15/h4-5,15H,6H2,1-3H3
|
|
InChIKey |
QVJKPZADVVATSS-UHFFFAOYSA-N
|
|
Synonyms |
6-Methoxymethyleugenin; 6-(Methoxymethyl)eugenin; CHEMBL463447; 5-hydroxy-7-methoxy-6-(methoxymethyl)-2-methylchromen-4-one; 5-Hydroxy-7-methoxy-6-methoxymethyl-2-methyl-chromen-4-one; 5-hydroxy-7-methoxy-6-(methoxymethyl)-2-methyl-4H-chromen-4-one; 4H-1-benzopyran-4-one, 5-hydroxy-7-methoxy-6-(methoxymethyl)-2-methyl-
|
|
CAS | NA | |
PubChem CID | 637447 | |
ChEMBL ID | CHEMBL463447 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 250.25 | ALogp: | 1.7 |
HBD: | 1 | HBA: | 5 |
Rotatable Bonds: | 3 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 65.0 | Aromatic Rings: | 2 |
Heavy Atoms: | 18 | QED Weighted: | 0.906 |
Caco-2 Permeability: | -4.731 | MDCK Permeability: | 0.00001030 |
Pgp-inhibitor: | 0.007 | Pgp-substrate: | 0.054 |
Human Intestinal Absorption (HIA): | 0.019 | 20% Bioavailability (F20%): | 0.008 |
30% Bioavailability (F30%): | 0.895 |
Blood-Brain-Barrier Penetration (BBB): | 0.273 | Plasma Protein Binding (PPB): | 74.03% |
Volume Distribution (VD): | 0.936 | Fu: | 27.19% |
CYP1A2-inhibitor: | 0.91 | CYP1A2-substrate: | 0.98 |
CYP2C19-inhibitor: | 0.093 | CYP2C19-substrate: | 0.817 |
CYP2C9-inhibitor: | 0.115 | CYP2C9-substrate: | 0.728 |
CYP2D6-inhibitor: | 0.04 | CYP2D6-substrate: | 0.765 |
CYP3A4-inhibitor: | 0.054 | CYP3A4-substrate: | 0.466 |
Clearance (CL): | 4.549 | Half-life (T1/2): | 0.781 |
hERG Blockers: | 0.013 | Human Hepatotoxicity (H-HT): | 0.118 |
Drug-inuced Liver Injury (DILI): | 0.47 | AMES Toxicity: | 0.528 |
Rat Oral Acute Toxicity: | 0.139 | Maximum Recommended Daily Dose: | 0.064 |
Skin Sensitization: | 0.528 | Carcinogencity: | 0.173 |
Eye Corrosion: | 0.004 | Eye Irritation: | 0.23 |
Respiratory Toxicity: | 0.229 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC004732 | 0.759 | D06GCK | 0.405 | ||||
ENC002207 | 0.759 | D0G4KG | 0.397 | ||||
ENC001495 | 0.704 | D0FA2O | 0.280 | ||||
ENC003982 | 0.592 | D0AO5H | 0.259 | ||||
ENC000962 | 0.574 | D04AIT | 0.259 | ||||
ENC002186 | 0.568 | D06QKV | 0.253 | ||||
ENC006031 | 0.559 | D0C1SF | 0.253 | ||||
ENC001518 | 0.534 | D07MGA | 0.250 | ||||
ENC004990 | 0.484 | D09PJX | 0.242 | ||||
ENC005716 | 0.475 | D02LZB | 0.240 |